Bausch Health Companies Inc. (NYSE:BHC) Shares Sold by Thompson Investment Management Inc.

Thompson Investment Management Inc. lessened its position in shares of Bausch Health Companies Inc. (NYSE:BHC) by 3.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 210,894 shares of the company’s stock after selling 7,966 shares during the quarter. Thompson Investment Management Inc. owned approximately 0.06% of Bausch Health Companies worth $2,238,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Nomura Holdings Inc. grew its position in shares of Bausch Health Companies by 67.7% in the third quarter. Nomura Holdings Inc. now owns 18,086,000 shares of the company’s stock valued at $148,667,000 after purchasing an additional 7,303,015 shares during the last quarter. Vanguard Group Inc. increased its position in Bausch Health Companies by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 11,599,131 shares of the company’s stock worth $93,025,000 after buying an additional 111,363 shares in the last quarter. Hudson Bay Capital Management LP raised its holdings in shares of Bausch Health Companies by 35.3% in the third quarter. Hudson Bay Capital Management LP now owns 11,500,000 shares of the company’s stock worth $94,530,000 after acquiring an additional 3,000,000 shares during the last quarter. Norges Bank purchased a new stake in shares of Bausch Health Companies in the fourth quarter valued at $31,121,000. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Bausch Health Companies by 0.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,866,886 shares of the company’s stock valued at $22,992,000 after acquiring an additional 15,495 shares during the last quarter. 78.65% of the stock is owned by institutional investors and hedge funds.

Bausch Health Companies Price Performance

Shares of BHC traded down $0.06 during mid-day trading on Wednesday, hitting $6.74. The company had a trading volume of 1,244,940 shares, compared to its average volume of 2,754,576. Bausch Health Companies Inc. has a 1-year low of $6.05 and a 1-year high of $11.46. The business’s 50-day simple moving average is $7.10 and its 200-day simple moving average is $8.10.

Bausch Health Companies (NYSE:BHC) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.16). Bausch Health Companies had a negative net margin of 5.07% and a negative return on equity of 2,370.91%. The company had revenue of $2.15 billion during the quarter, compared to analyst estimates of $2.18 billion. As a group, sell-side analysts expect that Bausch Health Companies Inc. will post 3.63 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Piper Sandler upped their target price on shares of Bausch Health Companies from $7.00 to $9.00 and gave the company a “neutral” rating in a report on Monday, April 29th. Royal Bank of Canada lowered their target price on shares of Bausch Health Companies from $12.00 to $11.00 and set a “sector perform” rating for the company in a research note on Tuesday, April 23rd. Finally, StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Wednesday, May 15th.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.